Detection of mesenchymal stem cells senescence by prelamin A accumulation at the nuclear level

Article English OPEN
Bellotti, Chiara ; Capanni, Cristina ; Lattanzi, Giovanna ; Donati, Davide ; Lucarelli, Enrico ; Duchi, Serena (2016)

Background Human mesenchymal stem cells (MSC), during in vitro expansion, undergo a progressive loss of proliferative potential that leads to the senescent state, associated with a reduction of their “medicinal” properties. This may hampers their efficacy in the treatment of injured tissues. Quality controls on MSC-based cell therapy products should include an assessment of the senescent state. However, a reliable and specific marker is still missing. From studies on lamin-associated disorders, has emerged the correlation between defective lamin A maturation and cellular senescence. Findings Primary cultured hMSC lines (n = 3), were analyzed by immunostaining at different life-span stages for the accumulation of prelamin A, along with other markers of cellular senescence. During culture, cells at the last stage of their life span displayed evident signs of senescence consistent with the positivity of SA-β-gal staining. We also observed a significant increase of prelamin A positive cells. Furthermore, we verified that the cells marked by prelamin A were also positive for p21Waf1 while negative for Ki67. Conclusions Overall data support that the detection of prelamin A identifies senescent MSC, providing an easy and reliable tool to be use alone or in combination with known senescence markers to screen MSC before their use in clinical applications. Electronic supplementary material The online version of this article (doi:10.1186/s40064-016-3091-7) contains supplementary material, which is available to authorized users.
  • References (38)
    38 references, page 1 of 4

    Banfi A, Muraglia A, Dozin B et al (2000) Proliferation kinetics and diefrentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 28:707-715

    Broers J, Ramaekers F (2006) Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev 86:967-1008. doi:10.1152/ physrev.00047.2005

    Caron M, Auclair M, Donadille B et al (2007) Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence. Cell Death Diefr 14:1759-1767. doi:10.1038/ sj.cdd.4402197

    Coppe J-P, Desprez P-Y, Krtolica A, Campisi J (2010) The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 5:99-118. doi:10.1146/annurev-pathol-121808-102144

    Crowe EP, Nacarelli T, Bitto A et al (2014) Detecting senescence: methods and approaches. In: Noguchi E, Gadaleta MC (eds) Cell cycle control. Springer, New York, NY, pp 425-445

    Davies BS, Cofinier C, Yang SH et al (2011) Investigating the purpose of prelamin A processing. Nucleus 2:4-9. doi:10.4161/nucl.2.1.13723

    de Girolamo L, Lucarelli E, Alessandri G et al (2013) Mesenchymal stem/stromal cells: a new cells as drugs' paradigm. Eficacy and critical aspects in cell therapy. Curr Pharm Des 19:2459-2473

    de Jesus BB, Blasco MA (2012) Assessing cell and organ senescence biomarkers. Circ Res 111:97-109. doi:10.1161/CIRCRESAHA.111.247866

    Debacq-Chainiaux F, Pascal T, Boilan E et al (2008) Screening of senescenceassociated genes with specific DNA array reveals the role of IGFBP-3 in premature senescence of human diploid fibroblasts. Free Radic Biol Med 44:1817-1832. doi:10.1016/j.freeradbiomed.2008.02.001

    Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O (2009) Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 4:1798-1806. doi:10.1038/nprot.2009.191

  • Related Research Results (3)
  • Metrics
    No metrics available
Share - Bookmark